Skip to main content

Taurine Partially Improves Abnormal Anxiety in Taurine-Deficient Mice

  • Conference paper
  • First Online:
Taurine 11

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1155))

Abstract

Taurine is abundant in various tissues including the brain, muscle, heart, spleen, liver and kidney with various physiological functions. Since taurine is produced by cysteine sulfinic acid decarboxylase (CSAD) in the liver and kidney, taurine-deficient mice without CSAD have been investigated for abnormal physiological functions such as retinal development, immune, pancreatic and liver function. In this study, the behavioral effects and abnormal brain development caused by low taurine in the developing brain were examined. In neonatal brains of homozygous CSAD knockout mice (HO), taurine was reduced by 85%, compared to wild-type mice (WT). Taurine was reduced by 35% in the brains of 2 month-old HO, compared to WT. Anxiety, motor coordination and autistic-like behaviors were evaluated at 2 months of age using five behavioral tests: elevated plus maze, open field, social approach, marble burying and accelerating rotarod. Mice were tested from 3 groups including WT, HO and HO with oral treatment of 0.2% taurine in the drinking water (HOT). HOT were born from HO dams treated with taurine from before pregnancy and were continuously treated with taurine in the drinking water after weaning. The taurine levels in the brain and plasma of HOT were restored to WT at 2 months of age. Taurine-deficiency did not lead to changes in autistic-like behaviors as the HO were not significantly different from WT in marble burying and social approach. However, taurine-deficiency increased anxiety-like behavior in HO in the elevated plus maze and open field, compared to WT. Taurine treatment significantly restored the HOT to WT levels of anxiety-like behavior in the elevated plus maze. However, changes in exploratory activity in the open field were not improved with taurine treatment. There was a slight difference in motor ability as the WT mice stayed on the accelerating rotarod longer that the HO and HOT, but the difference was significant in the HOT during the first trial only, compared to WT.

These data support hypothesis that taurine is essential for the emotional development of the brain. First, taurine is remarkably low in the neonatal brain of HO, compared to the adult brain of HO. Second, taurine treatment in HO partially improves anxiety-like behavior to WT.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 329.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 419.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 449.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

CSAD:

cysteine sulfinic acid decarboxylase

CSAD KO:

cysteine sulfinic acid decarboxylase knock-out mice

CDO:

cysteine dioxygenase

CDO KO:

cysteine dioxygenase knock-out mice

ADO:

cysteamine (2-aminoethanethiol) dioxygenase

GADL 1:

glutamate decarboxylase-like 1

GADL 1 KO:

glutamate decarboxylase-like 1 knock-out mice

TauT:

taurine transporter

TauT KO:

taurine transporter knock-out mice

WT:

wild-type mice (CSAD+/+)

HT:

heterozygotic mice (CSAD+/−)

HO:

homozygotic mice (CSAD−/−)

HOT:

homozygotic mice treated with 0.2% taurine in the drinking water

ASD:

autistic spectrum disorder

References

  • Aerts L, Van Assche GA (2002) Taurine and taurine-deficiency in the perinatal period. J Perinat Med 30(4):281–286

    CAS  PubMed  Google Scholar 

  • Aldred S, Moore KM, Fitzgerald M, Waring RH (2003) Plasma amino acid levels in children with autism and their families. J Autism Dev Disord 33(1):93–97

    PubMed  Google Scholar 

  • Anchan D, Clark S, Polland K, Vasudevan N (2014) GPR30 activation decreases anxiety in the open field test but not in the elevated plus maze test in female mice. Brain Behav 4(1):51–59

    PubMed  Google Scholar 

  • Arnold GL, Hyman SL, Mooney RA, Kirby RS (2003) Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies. J Autism Dev Disord 33(4):449–454

    PubMed  Google Scholar 

  • Asano A, Roman HB, Hirschberger LL, Ushiyama A, Nelson JL, Hinchman MM, Stipanuk MH, Travis AJ (2018) Cysteine dioxygenase is essential for mouse sperm osmoadaptation and male fertility. FEBS JFEBS J 285(10):1827–1839

    CAS  Google Scholar 

  • Barua S, Chadman KK, Kuizon S, Buenaventura D, Stapley NW, Ruocco F, Begum U, Guariglia SR, Brown WT, Junaid MA (2014) Increasing maternal or post-weaning folic acid alters gene expression and moderately changes behavior in the offspring. PLoS One 9(7):e101674

    PubMed  PubMed Central  Google Scholar 

  • Chadman KK (2011) Fluoxetine but not risperidone increases sociability in the BTBR mouse model of autism. Pharmacol Biochem Behav 97(3):586–594

    CAS  PubMed  Google Scholar 

  • Chadman KK, Gong S, Scattoni M, Boltuck S, Gandhy SU, Heintz N, Crawley J (2008) Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice. Autism Res 1(3):147–158

    PubMed  PubMed Central  Google Scholar 

  • Chen SW, Kong WX, Zhang YJ, Li YL, Mi XJ, Mu XS (2004) Possible anxiolytic effects of taurine in the mouse elevated plus-maze. Life Sci 75(12):1503–1511

    CAS  PubMed  Google Scholar 

  • Dela Rosa J, Stipanuk MH (1985) Evidence for a rate-limiting role of cysteine sulfinate decarboxylase activity in taurine biosynthesis in vivo. Comp Biochem Physiol 81(3):565–571

    Google Scholar 

  • Dominy JE, Simmons CR, Hirshberger LL, Hwang J, Coloso RM, Stipanuk MH (2007) Discovery and characterization of a second mammalian thiol dioxygenase, cysteamine dioxygenase. J Biol Chem 282:25189–25198

    CAS  PubMed  Google Scholar 

  • Elidrissi A, L’Amoreaux WJ (2008) Selective resistance of taurine-fed mice to isoniazide-potentiated seizures: in vivo functional test for the activity of glutamic acid decarboxylase. Neuroscience 156:693–699

    CAS  Google Scholar 

  • Elidrissi A, Boukarrou L, Heany W, Malliaros G, Sangdee C, Neuwirth L (2009a) Effects of taurine on anxiety-like and locomotor behavior of mice. Taurine improves learning and retention in aged mice. Adv Exp Med Biol 643:207–215

    CAS  Google Scholar 

  • Elidrissi A, Boukarrou L, Dobkin C, Brown WT (2009b) Taurine improves cognitive functions in a mouse model of fragile X syndrome. Adv Exp Med Biol 643:192–199

    Google Scholar 

  • Franconi F, Diana G, Fortuna A, Galietta G, Trombetta G, Valentini G, Seghieri G, Loizzo A (2004) Taurine administration during lactation modifies hippocampal CA1 neurotransmission and behavioural programming in adult male mice. Brain Res Bull 63(6):491–497

    CAS  PubMed  Google Scholar 

  • Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Geier MR (2009) Prospective study of transsulfuration biomarkers in autistic disorders. Neurochem Res 34:386–393

    CAS  PubMed  Google Scholar 

  • Ghanizadeh A (2013) Increased glutamate and homocysteine and decreased glutamine levels in autism: a review and strategies for future studies of amino acids in autism. Dis Markers 35(5):281–186

    PubMed  PubMed Central  Google Scholar 

  • Huxtable RJ (2000) Expanding the circle 1975–1999: sulfur biochemistry and insights on the biological functions of taurine. Adv Exp Med Biol 483:1–25

    CAS  PubMed  Google Scholar 

  • Imaki H, Neuringer M, Sturman JA (1996) Long-term effects on retina of rhesus monkeys fed taurine-free human infant formula. In: Huxtable R (ed) Taurine 2. Plenum Press, New York, pp 351–360

    Google Scholar 

  • Ito T, Kimura Y, Uozumi Y, Takai M, Muraoka S, Matsuda T, Ueki K, Yoshiyama M, Ikawa M, Okabe M, Schaffer SW, Fujio Y, Azuma J (2008) Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. J Mol Cell Cardiol 44:927–937

    CAS  PubMed  Google Scholar 

  • Jenness R (1979) The composition of human milk. Semin Perinatol 3(3):225–239

    CAS  PubMed  Google Scholar 

  • Kang YS, Ohtsuki S, Takanaga H, Tomi M, Terasaki T (2002) Regulation of taurine transport at the blood-brain barrier by tumor necrosis factor-alpha, taurine and hypertonicity. J Neurochem 83:1188–1895

    CAS  PubMed  Google Scholar 

  • Kong WX, Chen SW, Li YL, Zhang YJ, Wang R, Min L, Mi X (2006) Effects of taurine on rat behaviors in three anxiety models. Pharmacol Biochem Behav 83(2):271–276

    CAS  PubMed  Google Scholar 

  • Lanza A, Colombatto S (2008) Transport of amino acids through the placenta and their role. Amino Acids 34(4):517–523

    PubMed  Google Scholar 

  • Laurence JA, Fatemi SH (2005) Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects. Cerebellum 4:206–210

    CAS  PubMed  Google Scholar 

  • Liu F, Teng HY, Liu J, Wang HW, Zeng L, Zhao LF (2014) Antenatal taurine supplementation increases taurine content in intrauterine growth restricted fetal rat brain tissue. Metab Brain Dis 29(3):867–871

    PubMed  Google Scholar 

  • Liu F, Liu Y, Liu J, Ma LY (2015) Antenatal taurine improves intrauterine growth-restriced fetal rat brain development which is associated with increasing the activity of PKA-CaMKII/c-fos singal pathway. Neuropediatrics 46(5):299–306

    PubMed  Google Scholar 

  • Lu P, Schuller-Levis B, Sturman JA (1991) Distribution of taurine-like immunoreactivity in cerebellum of kittens from taurine-supplemented and taurine deficient mothers. Int J Dev Neurosci 6:621–629

    Google Scholar 

  • McCool BA, Chappell A (2004) Strychnine and taurine modulation of amygdala-associated anxiety-like behavior is ‘state’ dependent. Behav Brain Res 178(1):70–81

    Google Scholar 

  • Moreno H, Borjas L, Arrieta A, Saez L, Prassad A, Estevez J, Bonilla E (1992) Clinical heterogeneity of the autistic syndrome: a study of 60 families. Investig Clin 33(1):13–31

    CAS  Google Scholar 

  • Moreno-Fuenmayer H, Borjas L, Arrieta A, Valera V, Socorro-Candanoza L (1996) Plasma excitatory amino acids in autism. Investig Clin 37(2):113–128

    Google Scholar 

  • Neuwirth LS, Volpe NP, Elidrissi A (2013) Taurine effects on emotional learning and memory in aged mice: neurochemical alterations and differentiation in auditory cued fear and context conditioning. Adv Exp Med Biol 775:195–214

    CAS  PubMed  Google Scholar 

  • Park E, Park SY, Wang C, Xu J, LaFauci G, Schuller-Levis G (2002) Cloning of murine cysteine sulfinic acid decarboxylase and its mRNA expression in murine tissues. Biochim Biophys Acta 1574:403–406

    CAS  PubMed  Google Scholar 

  • Park E, Park YS, Dobkin C, Schuller-Levis G (2014) Development of a novel cysteine sulfinic acid decarboxylase knockout mouse: dietary taurine reduces neonatal mortality. J Amino Acids 2014:346809., 1–11. https://doi.org/10.1155/2014/346809

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Park E, Park SY, Dobkin C, Schuller-Levis G (2015) A novel cysteine sulfinic acid decarboxylase knock-out mouse: comparison between newborn and weanling mice. Adv Exp Med Biol 803:3–16

    CAS  PubMed  Google Scholar 

  • Park E, Cohen I, Gonzalez M, Castellano MR, Flory M, Jenkins EC, Brown WT, Schuller-Levis G (2017) Is taurine a biomarker in autistic spectrum disorder? Adv Exp Med Biol 975:3–16

    CAS  PubMed  Google Scholar 

  • Park E, Park SY, Cho IS, Kim BS, Schuller-Levis G (2017a) A novel cysteine sulfinic acid decarboxylase knock-out mouse: taurine distribution in various tissues with and without taurine supplementation. Adv Exp Med Biol 975:461–474

    CAS  PubMed  Google Scholar 

  • Park E, Park SY, Cho IS, Kim BS, Schuller-Levis G (2017b) A novel cysteine sulfinic acid decarboxylase knock-out mouse: immune function (II). Adv Exp Med Biol 975:449–460

    CAS  PubMed  Google Scholar 

  • Pow DV, Sullivan R, Reye P, Hermanussen S (2002) Localization of taurine transports, taurine and (3)H taurine accumulation in the rat retina, pituitary and brain. Glia 37:153–168

    PubMed  Google Scholar 

  • Ritvo ER, Freeman AB, Duong T, Robinson H, Guthrie D, Ritvo A (1986) Lower Purkinje cell counts in the cerebella of four autistic subjects: initial finding of the UCLA-NSAC autopsy research report. Am J Psychiatry 143:862–866

    CAS  PubMed  Google Scholar 

  • Roos S, Powell TL, Jansson T (2004) Human placental taurine transport in uncomplicated and IUGR pregnancies: cellular localization, protein expression and regulation. Am J Physiol Regul Integr Comp Physiol 287:R886–R893

    CAS  PubMed  Google Scholar 

  • Schaffer SW, Azuma J, Mozaffari M (2009) Role of antioxidant activity of taurine in diabetes. Can J Physiol Pharmacol 87(2):91–99

    CAS  PubMed  Google Scholar 

  • Schuller-Levis GB, Park E (2003) Taurine: new implications for an old amino acid. FEMS Microbiol Lett 226:195–202

    CAS  PubMed  Google Scholar 

  • Schuller-Levis G, Park E (2006) Is taurine a biomarker? Adv Clin Chem 41:1–21

    CAS  PubMed  Google Scholar 

  • Schuller-Levis G, Gordon R, Wang C, Park S, Park E (2009) Protection of bleomycin-induced fibrosis and inflammation by taurine. Int Immunopharmacol 9:971–977

    CAS  PubMed  Google Scholar 

  • Sidime F, Philips G, LaMassa N, Park E, Elidrissi A (2017) Glucose homeostasis and retinal histology in CSAD KO mice. Adv Exp Med Biol 975:503–511

    CAS  PubMed  Google Scholar 

  • Stanford WL, Epp T, Reid T, Rossant J (2006) Gene trapping in embryonic stem cells. Methods Enzymol 420:136–162

    CAS  PubMed  Google Scholar 

  • Stipanuk MH (2004) Role of the liver in regulation of body cysteine and taurine levels: a brief review. Neurochem Res 29(1):105–110

    CAS  PubMed  Google Scholar 

  • Sturman JA (1993) Taurine in development. Physiol Rev 73:119–146

    CAS  PubMed  Google Scholar 

  • Tu WJ, Chen H, He J (2012) Application of LC/MS/MS analysis of plasma amino acids profiles in children with autism. J Clin Bichem and Nutri 51(3):248–249

    CAS  Google Scholar 

  • Ueki I, Roman HB, Valli A, Fieselmann K, Lam J, Peters R, Hirschberger LL, Stipanuk MH (2011) Knockout of the murine cysteine dioxygenase gene results in severe impairment in ability to synthesize taurine and an increased catabolism of cysteine to hydrogen sulfide. Am J Physiol Endocrinol Metab 301:E668–E684

    CAS  PubMed  PubMed Central  Google Scholar 

  • Wang Y, Fu W, Liu J (2016) Neurodeveloment in children with intrauterine growth restriction: adverse effects and intervetions. J Matern Fatal Neonatal Med 29(4):660–668

    CAS  Google Scholar 

  • Warsulat U, Heller-Stilb B, Oermann E, Zilles K, Haas H, Lang F, Haessinger D (2007) Phenotype of the taurine transporter knockout mouse. Methods Enzymol 428:439–458

    Google Scholar 

  • Weidner KL, Buenaventura D, Chadman KK (2014) Mice over-expressing BDNF in forebrain neurons develop an altered behavioral phenotype with age. Behav Brain Res 268:222–228

    CAS  PubMed  Google Scholar 

  • Wharton BA, Morley R, Isaacs EB, Cole TJ, Lucas A (2004) Low plasma taurine and later neurodevelopment. Arch Dis Child Fetal Neonatal Ed 89(6):F97–F98

    Google Scholar 

  • Winge I, Teigen K, Fossbakk A, Mahootchi E, Kieppe R, SKoelberg F, Kaempe O, Haavik J (2015) Mammalian CSAD and GADL-1 have distinct biochemical properites and patterns of brain expression. Neurochem Int 90:173–184

    CAS  PubMed  Google Scholar 

  • Wu GF, Ren S, Tang RY, Xu C, Zhou JQ, Lin SM, Feng Y, Yang QH, Hu JM, Yang JC (2017) Antidepressant effect of taurine in chronic unpredictable mild stress-induced depressive rats. Sci Rep 7(1):4989–4996

    PubMed  PubMed Central  Google Scholar 

  • Xu Y, Lu P, Imaki H, Sturman JA (1992) Feline maternal deficiency: a quantitative morphometric and immunohistochemical study of newborn visual cortex. Dendron 1:129–145

    CAS  Google Scholar 

  • Zhang CG, Kim SJ (2007) Taurine induces anti-anxiety by activating strychnine-sensitive glycine receptor in vivo. Ann Nutr Metab 51(4):379–386

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the Office for People with Developmental Disabilities, Albany, NY and Dong A Pharmaceutical Co., LTD, Seoul, Korea. We are thankful to Dr. William Levis and H Cliff Meeker for discussing the research and reviewing this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eunkyue Park .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Park, E., Elidrissi, A., Schuller-Levis, G., Chadman, K.K. (2019). Taurine Partially Improves Abnormal Anxiety in Taurine-Deficient Mice. In: Hu, J., Piao, F., Schaffer, S., El Idrissi, A., Wu, JY. (eds) Taurine 11. Advances in Experimental Medicine and Biology, vol 1155. Springer, Singapore. https://doi.org/10.1007/978-981-13-8023-5_76

Download citation

Publish with us

Policies and ethics